Integrated Clinical Trial Services Launches Medical Science Liaison Program


Local Clinical Services Firm Offers Liaison Services And Optimization For Pre-Existing Programs



[ClickPress, Fri Jan 02 2009] Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that the firm has launched its Medical Science Liaison (MSL) Program. The program, to be led by David M. Shearer, MD, chief medical officer and vice president of clinical operations for ICTS, allows pharmaceutical, biotechnology or medical device sponsors to better communicate key information regarding new products and medical therapies to the medical community through contracted healthcare consulting professionals. The MSL process can strengthen a product or therapy’s market penetration by properly relaying vital information that educates key opinion leaders on a product or therapy and will create opportunities for product implementation.

The ICTS liaisons can provide a comprehensive, turnkey MSL program for sponsors, or they can optimize a sponsor’s pre-existing program structure. Each of the firm’s liaisons has an advanced scientific degree (MD, PhD or PharmD), and all have significant MSL experience. For more information, visit www.integratedtrials.com.

Related Links:
www.integratedtrials.com
www.mmimarketing.com

News Facts:
• Tom Sturgis, president of Integrated Clinical Trial Services (ICTS), a full-service patient enrollment firm that utilizes more than 300 contract employees internationally to provide clinical trial patient recruitment, enrollment, retention and adherence, has announced that the firm has launched its Medical Science Liaison (MSL) Program.
• The program, to be led by David M. Shearer, MD, chief medical officer and vice president of clinical operations for ICTS, allows pharmaceutical, biotechnology or medical device sponsors to better communicate key information regarding new products and medical therapies to the medical community through contracted healthcare consulting professionals.
• The MSL process can strengthen a product or therapy’s market penetration by properly relaying vital information that educates key opinion leaders on a product or therapy and will create opportunities for product implementation.
• The ICTS liaisons can provide a comprehensive, turnkey MSL program for sponsors, or they can optimize a sponsor’s pre-existing program structure.
• Each of the firm’s liaisons has an advanced scientific degree (MD, PhD or PharmD), and all have significant MSL experience.
• For more information, visit www.integratedtrials.com.

Quotes:
“We are excited about launching the Medical Science Liaison Program,” said David Shearer. “Establishing credibility with these leaders is critical to successful product launches and continuing education.”

About Integrated Clinical Trial Services:
Integrated Clinical Trial Services is a creative, innovative and flexible partner for clinical trial patient recruitment, enrollment, retention and adherence. The full-service firm utilizes more than 300 contract employees internationally to provide patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more. The Integrated Clinical Trial Services management team has completed more than 300 successful patient recruitment programs and combines for more than 60 years of active involvement in patient accrual. A successful trial depends on the quality of the underlying recruitment plan and Integrated Clinical Trial Services is dedicated to constructing the right solution based upon each client’s protocol and needs. For more information please call (919) 388-3964 or visit the Web site at www.integratedtrials.com.

Keywords:
Integrated Clinical Trial Services, ICTS, Tom Sturgis, clinical trial, clinical research industry, patient enrollment, clinical trial sponsors, recruitment strategy, compliance, retention, David M. Shearer, MD, medical science liaison, MSL program

Patty Briguglio
MMI Associates, Inc.
(919) 233-6600
patty@mmimarketing.com
PR Firms Raleigh, NC

(end)

Company: MMI ASSOCIATES, INC.


Contact Name:

Contact Email: onlinenews@mmimarketing.com

Contact Phone: 919-233-6600

>>Visit website